Zhou et al.[214] further explored the role of VEGF‐C that promotes MLV generation in anti‐immunity and confirmed that overexpression of VEGF‐C enhances the anti‐tumor immune effect of RT through the CCL21 pathway. The gene discussed is VEGFC; the disease is neoplasm.